Skip to content
approvals
-
Roche obtains CE mark for first blood-based ApoE4 Alzheimer’s test
Alzheimer’s disease drives up to 70% of dementia cases worldwide, presenting healthcare systems with mounting challenges.
-
Moderna’s combination Covid-Flu vaccine clears key European regulatory hurdle
The EMA will now proceed with a final decision, potentially clearing the way for global distribution of this combination immunization.
-
Mubadala Bio’s subsidiary secures prestigious EU Quality certification
EU GMP certification confirms that Bioventure Healthcare meets the European Union’s demanding requirements for pharmaceutical manufacturing.